Immuneering (IMRX) Return on Sales (2020 - 2023)
Immuneering's (IMRX) quarterly Return on Sales came in at 1933.95% in Q3 2023, down 192383.0% year-on-year from N/an in Q3 2022, and down 7346.43% quarter-over-quarter from 25.97% in Q2 2023.
Immuneering (IMRX) Return on Sales (2020 - 2023) Analysis & Trends
Immuneering's Return on Sales history runs 4 years deep, the most recent figure standing at 1933.95% for Q3 2023.
- On a quarterly basis, Return on Sales fell 192383.0% year-over-year to 1933.95% in Q3 2023; TTM through Sep 2023 was 1933.95%, a 193223.0% decrease from a year earlier, with the FY2022 full-year figure at 1.59%, down 143.0% from the prior year.
- Return on Sales retreated to 1933.95% in Q3 2023 per IMRX's latest filing, from 25.97% in the prior quarter.
- Across five years, Return on Sales topped out at 0.06% in Q3 2020 and bottomed at 1933.95% in Q3 2023.
- The 4-year median for Return on Sales is 1.16% (2021), against an average of 162.92%.
- Across the five-year window, Return on Sales declined 22 bps in 2021 and slumped 192383 bps in 2023, its largest moves.
- Year by year, Return on Sales stood at 0.09% in 2020, then slumped by 558 bps to 0.58% in 2021, then plunged by 51406 bps to 298.87% in 2022, then sank by 547 bps to 1933.95% in 2023.
- Per Business Quant, the three latest IMRX Return on Sales figures stand at 1933.95% (Q3 2023), 25.97% (Q2 2023), and 6.45% (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 0.00% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -1,933.95% |
| Jun 30, 2023 | -25.97% |
| Mar 31, 2023 | -6.45% |
| Dec 31, 2022 | -298.87% |
| Sep 30, 2022 | -10.12% |
| Jun 30, 2022 | -2.05% |
| Mar 31, 2022 | -0.98% |
| Dec 31, 2021 | -0.58% |
| Sep 30, 2021 | -1.35% |
| Jun 30, 2021 | -0.30% |
| Mar 31, 2021 | -0.08% |
| Dec 31, 2020 | -0.09% |
| Sep 30, 2020 | -0.06% |
| Jun 30, 2020 | -0.07% |